Pharmaceuticals - Belgium

Belgium

In 2024, the projected revenue in the Pharmaceuticals market in Belgium is expected to reach US$5.56bn.
Among the various markets, the largest one is Oncology Drugs, which is projected to have a market volume of US$1.11bn in 2024.
Looking ahead, the market is anticipated to grow at an annual growth rate of 6.00% (CAGR 2024-2028), resulting in a market volume of US$7.02bn by 2028.
When compared to global markets, it is important to note that United States is forecasted to generate the highest revenue, with US$636.90bn in 2024.
Belgium's pharmaceutical industry is thriving, with a strong emphasis on research and development, making it a hub for innovation in healthcare.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

Belgium, a country located in Western Europe, is known for its chocolate, waffles, and beer. However, the country also has a thriving pharmaceuticals market.

Customer preferences: Belgian consumers have a high demand for pharmaceutical products due to the country's aging population and the prevalence of chronic diseases. The government's healthcare system also plays a significant role in shaping customer preferences, as it heavily subsidizes medication costs for citizens.

Trends in the market: Pharmaceutical companies in Belgium are focusing on research and development to create innovative drugs to meet the needs of the aging population. There has been a trend towards personalized medicine, which tailors treatments to the specific needs of individual patients. Additionally, there is a growing interest in natural and alternative medicines, leading to an increase in the production of homeopathic remedies.

Local special circumstances: Belgium's central location in Europe makes it an attractive location for pharmaceutical companies to establish their headquarters. The country also has a highly skilled workforce and a favorable business environment, making it an ideal location for research and development activities.

Underlying macroeconomic factors: The Belgian pharmaceuticals market is heavily regulated by the government, which sets prices for medication and controls the reimbursement system. The country's strong economy and stable political environment have also contributed to the growth of the pharmaceuticals industry. However, the industry is facing challenges such as rising healthcare costs and increasing pressure to reduce drug prices. In conclusion, the pharmaceuticals market in Belgium is driven by the country's aging population, high demand for medication, and government subsidies. Companies are focusing on research and development to create innovative drugs and personalized medicine. Belgium's central location, skilled workforce, and favorable business environment make it an attractive location for pharmaceutical companies. However, the industry is facing challenges such as rising healthcare costs and increasing pressure to reduce drug prices.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.